|
|
|
|
LEADER |
01310nam a2200289 u 4500 |
001 |
EB001999330 |
003 |
EBX01000000000000001162231 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Seidenfeld, Jerome
|
245 |
0 |
0 |
|a Uses of epoetin for oncology
|h Elektronische Ressource
|c prepared by Blue Cross and Blue Shield Association, Technology Evaluation Center ; Jerome Seidenfeld, principal investigator ; Naomi Aronson ... [et al.], investigators
|
260 |
|
|
|a Bethesda, MD
|b Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services
|c [2001], 2001
|
300 |
|
|
|a ix, 330 p
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Erythropoietin / therapeutic use
|
653 |
|
|
|a Anemia / drug therapy
|
653 |
|
|
|a Neoplasms / complications
|
700 |
1 |
|
|a Aronson, Naomi
|
710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
710 |
2 |
|
|a Blue Cross and Blue Shield Association
|b Technology Evaluation Center
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Evidence report/technology assessment
|
500 |
|
|
|a "June 2001."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK33589
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|